| Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients G Kallergi, MA Papadaki, E Politaki, D Mavroudis, V Georgoulias, ... Breast Cancer Research 13, 1-11, 2011 | 448 | 2011 |
| Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer PA Theodoropoulos, H Polioudaki, S Agelaki, G Kallergi, Z Saridaki, ... Cancer letters 288 (1), 99-106, 2010 | 366 | 2010 |
| Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early … M Ignatiadis, G Kallergi, M Ntoulia, M Perraki, S Apostolaki, M Kafousi, ... Clinical Cancer Research 14 (9), 2593-2600, 2008 | 294 | 2008 |
| Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells … V Georgoulias, V Bozionelou, S Agelaki, M Perraki, S Apostolaki, ... Annals of oncology 23 (7), 1744-1750, 2012 | 173 | 2012 |
| Phosphorylated EGFR and PI3K/Akt signaling kinases are expressed in circulating tumor cells of breast cancer patients G Kallergi, S Agelaki, A Kalykaki, C Stournaras, D Mavroudis, ... Breast cancer research 10, 1-11, 2008 | 165 | 2008 |
| Hypoxia-inducible factor-1α and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients G Kallergi, H Markomanolaki, V Giannoukaraki, MA Papadaki, A Strati, ... Breast Cancer Research 11, 1-12, 2009 | 158 | 2009 |
| Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer MA Papadaki, G Kallergi, Z Zafeiriou, L Manouras, PA Theodoropoulos, ... BMC cancer 14, 1-10, 2014 | 124 | 2014 |
| Activation of FAK/PI3K/Rac1 signaling controls actin reorganization and inhibits cell motility in human cancer cells G Kallergi, S Agelaki, H Markomanolaki, V Georgoulias, C Stournaras Cellular Physiology and Biochemistry 20 (6), 977-986, 2007 | 123 | 2007 |
| Apoptotic circulating tumor cells in early and metastatic breast cancer patients G Kallergi, G Konstantinidis, H Markomanolaki, MA Papadaki, ... Molecular cancer therapeutics 12 (9), 1886-1895, 2013 | 105 | 2013 |
| Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse E Saloustros, M Perraki, S Apostolaki, G Kallergi, A Xyrafas, K Kalbakis, ... Breast cancer research 13, 1-11, 2011 | 94 | 2011 |
| Phosphorylation of FAK, PI-3K, and impaired actin organization in CK-positive micrometastatic breast cancer cells G Kallergi, D Mavroudis, V Georgoulias, C Stournaras Molecular Medicine 13, 79-88, 2007 | 93 | 2007 |
| Evaluation of isolation methods for circulating tumor cells (CTCs) G Kallergi, E Politaki, S Alkahtani, C Stournaras, V Georgoulias Cellular Physiology and Biochemistry 40 (3-4), 411-419, 2016 | 76 | 2016 |
| Efficacy of lapatinib in therapy-resistant HER2-positive circulating tumor cells in metastatic breast cancer S Agelaki, A Kalykaki, H Markomanolaki, MA Papadaki, G Kallergi, ... PloS one 10 (6), e0123683, 2015 | 73 | 2015 |
| Evaluation of PD-L1/PD-1 on circulating tumor cells in patients with advanced non-small cell lung cancer G Kallergi, EK Vetsika, D Aggouraki, E Lagoudaki, A Koutsopoulos, ... Therapeutic advances in medical oncology 10, 1758834017750121, 2018 | 72 | 2018 |
| Membrane androgen receptor activation in prostate and breast tumor cells: molecular signaling and clinical impact N Papadopoulou, EA Papakonstanti, G Kallergi, K Alevizopoulos, ... IUBMB life 61 (1), 56-61, 2009 | 71 | 2009 |
| Caveolin-1 regulates EGFR signalling in MCF-7 breast cancer cells and enhances gefitinib-induced tumor cell inhibition S Agelaki, M Spiliotaki, H Markomanolaki, G Kallergi, D Mavroudis, ... Cancer biology & therapy 8 (15), 1470-1477, 2009 | 67 | 2009 |
| Detection of occult HER2 mRNA-positive tumor cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic relevance S Apostolaki, M Perraki, G Kallergi, M Kafousi, S Papadopoulos, ... Breast cancer research and treatment 117, 525-534, 2009 | 63 | 2009 |
| Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancy M Spiliotaki, D Mavroudis, K Kapranou, H Markomanolaki, G Kallergi, ... Breast Cancer Research 16, 1-13, 2014 | 62 | 2014 |
| Breast cancer metastasis suppressor-1 promoter methylation in primary breast tumors and corresponding circulating tumor cells M Chimonidou, G Kallergi, V Georgoulias, DR Welch, ES Lianidou Molecular Cancer Research 11 (10), 1248-1257, 2013 | 60 | 2013 |
| A comparison of three methods for the detection of circulating tumor cells in patients with early and metastatic breast cancer E Politaki, S Agelaki, S Apostolaki, D Hatzidaki, A Strati, F Koinis, ... Cellular Physiology and Biochemistry 44 (2), 594-606, 2017 | 43 | 2017 |
